Takeda Pharmaceutical Li... (TAK)
NYSE: TAK
· Real-Time Price · USD
14.96
0.16 (1.08%)
At close: Aug 15, 2025, 12:30 PM
Takeda Pharmaceutical Cash Flow Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -103.2B | 23.79B | 92.05B | 95.25B | -3.02B | 105.75B | -47.97B | 89.41B | 31.14B | 119.15B | 61.73B | 105.02B | -11.38B | 57.82B | 45.99B | 137.73B |
Depreciation & Amortization | 189.77B | 186.96B | 192.45B | 192.22B | 186.74B | 187.06B | 182.7B | 171.5B | 161.41B | 176.88B | 167.83B | 158.28B | 152.27B | 147.28B | 140.65B | 142.95B |
Stock-Based Compensation | 17.63B | 18.3B | n/a | 15.39B | 18.19B | 18.71B | 18.54B | 15.44B | 14.85B | 16.49B | 17.04B | 12.29B | 11.32B | 11.09B | 12.43B | 8.55B |
Other Working Capital | 11.39B | 35.22B | -29.65B | -94.7B | 42.9B | -200.02B | 48.67B | -22.58B | 59.87B | 64.71B | 3.25B | -20.11B | 12.01B | -51.52B | 26.52B | -65.22B |
Other Non-Cash Items | 125.42B | 85.58B | 54.95B | 541.6B | 307.01B | 45.45B | 92.06B | -78.63B | -73.87B | 26.4B | 3.06B | -53.34B | 87.36B | 45.34B | 9.42B | -46.72B |
Deferred Income Tax | n/a | n/a | n/a | 41.3B | -44.53B | -44.5B | -48.01B | 45.63B | 16.78B | -12B | 2.82B | 50.45B | -42.67B | 14.37B | 15.45B | 85.25B |
Change in Working Capital | -7.46B | 69.13B | -80.45B | -189.98B | 99.06B | -166.02B | 1.59B | -150.95B | 143.39B | 51.3B | -31.49B | -188.47B | 178.68B | 71.61B | 9.21B | -160.9B |
Operating Cash Flow | 222.16B | 383.76B | 259B | 159.38B | 272.47B | 146.45B | 198.91B | 92.4B | 293.69B | 378.23B | 220.99B | 84.24B | 375.58B | 347.51B | 233.15B | 166.86B |
Capital Expenditures | -48.79B | -45.09B | -49.47B | -137.8B | -64.33B | -77.12B | -70.04B | -269.24B | -444.08B | -50.62B | -40.61B | -98.38B | -51.82B | -48.43B | -43.49B | -42.29B |
Cash Acquisitions | n/a | n/a | 5.42B | 2.95B | -13.7B | -26.25B | -7M | 372M | 7.96B | -15.02B | -7.99B | -55.61B | 26.06B | -22.12B | -10.64B | -25.41B |
Purchase of Investments | n/a | n/a | -10.05B | -12.98B | -2.04B | -2.46B | -1.59B | -674M | -4.71B | -747M | -1.76B | -2.93B | -741M | -4.01B | -340M | -3.25B |
Sales Maturities Of Investments | n/a | n/a | 17.8B | 5.32B | 6.93B | 458M | 88M | 543M | 1.7B | 2.15B | 12.22B | 6.18B | 856M | 6B | 9.59B | 483M |
Other Investing Acitivies | 29.11B | -70.47B | -32.49B | -18.72B | -3.92B | 30.11B | 10.97B | 2.47B | 639M | 17.55B | 10.93B | 56.03B | 12M | -21.93B | -11.39B | 26M |
Investing Cash Flow | -19.68B | -115.56B | -80B | -161.23B | -77.06B | -75.27B | -60.58B | -266.53B | -438.49B | -46.69B | -27.21B | -94.71B | -25.64B | -69.14B | -32.9B | -70.44B |
Debt Repayment | -547.99B | -470.88B | -57.09B | 440.53B | -11.28B | -96.51B | -157.07B | 99.37B | 29.02B | -266.2B | -10.77B | -37.13B | -184.86B | 45.99B | -208.36B | -253.25B |
Common Stock Repurchased | -49.98B | n/a | n/a | -1.88B | n/a | n/a | n/a | -2.33B | n/a | n/a | n/a | -26.93B | -24.99B | -50B | n/a | -2.54B |
Dividend Paid | -9.74B | -145.45B | -9.2B | -138.11B | -9.13B | -138.25B | -9.06B | -130.75B | -10.42B | -128.99B | -11.13B | -128.87B | -10.64B | -131.45B | -9.54B | -132.03B |
Other Financial Acitivies | 305.92B | -39.64B | -16.93B | 31.31B | -37.82B | 137B | 25.48B | -24.07B | -25.2B | -39.77B | -29.98B | -22.79B | -23.31B | -32.6B | -29.46B | -23.22B |
Financial Cash Flow | -301.79B | -655.97B | -83.21B | 331.85B | -36.53B | -97.76B | -140.66B | -57.78B | -6.6B | -434.95B | -51.88B | -215.72B | -243.8B | -168.06B | -247.37B | -411.04B |
Net Cash Flow | -109.01B | -364.89B | 54.74B | 599.08B | 169.44B | -29.69B | 1.67B | -217.15B | -151.61B | -113B | 152.15B | -203.7B | 125.35B | 116.46B | -47.04B | -311.3B |
Free Cash Flow | 173.37B | 338.67B | 209.53B | 21.58B | 208.15B | 69.33B | 128.86B | -176.84B | -150.39B | 327.61B | 180.38B | -14.13B | 323.76B | 299.08B | 189.66B | 124.57B |